What if aggressive cancer is missed because of extra gene copies? #shorts
23 Mar 2026 · 0 min
0:22
In this short video, Dino Prato warns that many physicians fail to test for extra copies of oncogenes in aggressive cancers. Because of this oversight, patients often receive high‑dose, non‑targeted chemotherapy, which can worsen outcomes. Prato stresses that the key to improving survival is deep genetic testing and advanced technology to identify these extra gene copies and guide precise, targeted therapies.
